Prophylactic steroids for pediatric open heart surgery.

Area of Science:

• Pediatric Cardiac Surgery
• Immunology
• Pharmacology

Background:

• Cardiopulmonary bypass in pediatric patients can trigger an immune response, leading to postoperative complications like hemodynamic instability, infections, and arrhythmias.
• Prophylactic corticosteroids are sometimes administered to mitigate this inflammatory response, but their efficacy and safety in children remain uncertain.

Purpose of the Study:

• To systematically review the benefits and harms of prophylactic corticosteroid administration versus placebo in pediatric open-heart surgery.

Main Methods:

• Searched multiple databases (Cochrane, MEDLINE, EMBASE) and grey literature without language restrictions.
• Included randomized and quasi-randomized controlled trials of pediatric open-heart surgery involving corticosteroid administration.
• Abstracted data and performed meta-analyses using a random-effects model.

Main Results:

• All-cause mortality data was incomplete and could not be assessed.
• Weak evidence suggested potential reductions in intensive care unit stay, peak core temperature, and duration of ventilation with prophylactic corticosteroids.

Conclusions:

• The existing evidence does not support the routine use of prophylactic steroids in pediatric patients undergoing cardiopulmonary bypass surgery to reduce postoperative complications.
• Further well-designed, adequately powered randomized controlled trials are necessary to clarify the benefits and harms of this intervention.